SEC
Former Precipio CFO, Son Agree to Settle SEC Insider Trading Lawsuit
Former Precipio CFO Carl Iberger was charged with providing confidential information regarding a company distribution deal for a COVID-19 test.
CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC
The molecular diagnostics company reported $75.6 million in revenues for the quarter and said testing service revenues rose 46 percent year over year.
Cue Health Files for IPO for up to $100M
The company developed its portable Cue Integrated Care Platform for molecular SARS-CoV-2 testing and received an EUA for its test in June 2020.
Talis Biomedical 2020 Revenues Rise Sharply
The company also said it is planning on filing for Emergency Use Authorization for its SARS-CoV-2 test in the second quarter of 2021.
SEC Sues Founders of Bankrupt Human Microbiome Testing Firm uBiome For Fraud
The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018.
Nov 13, 2020
Abbott Enters $5B Credit Agreement
Sep 11, 2020
Hologic Raises Q4 Revenue Guidance
Sep 9, 2020
Early Cancer Detection Firm Grail Files for IPO
Jun 16, 2020
Progenity Eyes $122.6M in Amended IPO
Jun 15, 2020
Genetron Health Targeting $175.5M in Amended US IPO
Jun 7, 2020
ArcherDx Targeting $100M in IPO
Feb 12, 2020
OpGen Preliminary 2019 Revenues up 19 Percent
Dec 17, 2019
Grail Raises $125M in Equity Financing Offering
Nov 25, 2019
Oct 15, 2019
OpGen Plans $10.4M Stock, Warrant Sale
Sep 19, 2019